PTEN and neurodegenerative disease: Since an elevated PI3K/AKT signaling pathway has been demonstrated to be beneficial in physiological processes that require cell regeneration, inhibiting PTEN, a negative regulator of this pathway, has been considered a prospective therapy for neurodegenerative diseases, ischemia, infection, and insulin-resistant metabolic disorders [14].